...
【24h】

Patterns of failure following curative resection of colorectal liver metastases.

机译:治愈性切除大肠肝转移瘤后的衰竭模式。

获取原文
获取原文并翻译 | 示例

摘要

AIMS: Several studies have focused on factors determining recurrence and survival rate after curative resection of colorectal liver metastases (LM). Data are lacking with regard to patterns of failure indicating where and when recurrences arise.METHODS: One-hundred-and-five consecutive patients [F/M: 31/74; mean age 61 years (range 36-80y)] with primary colorectal liver metastases underwent surgical R0 curative resection between 1990-1999. Patient follow-up was closed in January 2002. The common closing date method was used for survival analysis. Multivariate analysis was performed with the Cox proportional hazard technique.RESULTS: The overall (OS) vs disease free survival (DFS) rates at 1, 2, and 5 years were 88.5 vs 63.3, 73.4 vs 40.2, and 36.8 vs 18.1%, respectively. Elevated serum CEA level was the only factor independently related to recurrent disease. Elevated serum CEA level, maximum diameter of liver metastases (LM), and satellitosis were factors significantly related to poor OS. Recurrent liver metastases developed in 43% and extra-hepatic metastases in 60% of the patients. In about half of the patients cancer recurrence was observed within 18 months, almost equally distributed between hepatic and extra-hepatic sites.CONCLUSION: Despite optimal patient selection and curative resection of colorectal liver metastases, more than a half of the patients developed cancer recurrence within 2 years.
机译:目的:几项研究集中在决定根治性切除大肠肝转移(LM)后复发和生存率的因素。缺乏有关失败模式的数据,该数据表明了何时何处复发。平均年龄61岁(范围36-80岁)],1990年至1999年间接受外科R0根治性手术治疗了原发性结直肠肝转移。患者随访于2002年1月结束。生存期采用通用的截止日期方法。结果:Cox比例风险技术在1、2和5年的总生存率与无病生存率分别为88.5、63.3、73.4、40.2和36.8、18.1%。 。血清CEA水平升高是与复发性疾病独立相关的唯一因素。血清CEA水平升高,肝转移最大直径(LM)和卫星变形是与OS差有关的重要因素。复发的肝转移发生在43%,肝外转移发生在60%的患者中。结论:尽管有最佳的患者选择和根治性切除大肠肝转移的机会,但大约一半的患者在18个月内观察到了癌症复发,在肝内和肝外部位之间的分布几乎相等。 2年。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号